Product
Paclitaxel Polymeric Micelles
1 clinical trial
1 indication
Indication
Metastatic Breast CancerClinical trial
A Randomized, Controlled Phase Ⅲ Study of Paclitaxel Polymeric Micelles for Injection Versus Physician's Choice(TPC) in Human Epidermal Growth Factor Receptor 2-negative (HER2-) Metastatic Breast Cancer (MBC) Subjects Who Have Failed at Least Two Previous Chemotherapy Regimens.Status: Recruiting, Estimated PCD: 2025-07-01